Agenda

Wednesday, May 30, 2012

Pre-conference Courses (separate registration required)
8:00am-6:00pm	Masters in Lipidology™ Course
8:00am-5:00pm	Translation of HDL Science Master Class
8:00am-5:00pm	Society of Atherosclerosis Imaging and Prevention (SAIP) CIMT Training Academy (endorsed by the NLA)
10:00am-5:30pm	NLA Lipid Academy™

Thursday, May 31, 2012

Pre-conference Courses (separate registration required)
7:30am-3:00pm	Masters in Lipidology™ Course
8:00am-12:00pm	Translation of HDL Science Master Class
8:00am-1:00pm	Society of Atherosclerosis Imaging and Prevention (SAIP) CIMT Training Academy (endorsed by the NLA)
8:00am-12:00pm	NLA Lipid Academy™

Thursday, May 31, 2012 - Scientific Sessions Begin

3:00-6:30 pm	Masters Summit on Emerging LDL Therapies	Chair: Michael H. Davidson, MD, FNLA
3:00-3:30 pm	Mechanisms of Atherosclerotic Plaque Progression	Ira Tabas, MD, PhD
3:30-4:00 pm	Using Human Genetics to Discover New Therapeutic Targets for Plasma Lipids	Jonathan C. Cohen, PhD
4:00-4:30 pm	Mipomersen: Antisense Oligonucleotide Therapy in the Management of Dyslipidemia	Peter P. Toth, MD, PhD, FNLA
4:30-5:00 pm	PCSK9 Targeted Monoclonal Antibodies: Mechanism of Action, Clinical Efficacy and Safety	Michael H. Davidson, MD, FNLA
5:00-5:30 pm	Microsomal Transfer Protein Inhibitors	Anne C. Goldberg, MD, FNLA
5:30-6:00 pm	Management of Severely Elevated LDL-Cholesterol: The Role of LDL Apheresis	Mary P. McGowan, MD, FNLA
6:00-6:30 pm	Q&A
6:30-7:30 pm	Welcome Reception in Exhibit Hall
7:30-9:30 pm	Satellite Dinner Symposium: The Emergent Science of HDL and its Metabolism: Mechanistic Understanding of CETP Antagonism and Beyond

Friday, June 1, 2012

7:00-8:00 am	Breakfast in Exhibit Hall
7:50-8:00am	NLA News and Business I (SELA)
8:00-9:00 am	Keynote Address and Opening Sessions	Chair: Penny Kris-Etherton, PhD, RD, CLS, FNLA
8:00-8:45 am	Keynote Presentation: Importance of Comparative Effectiveness Strategy Trials in Clinical Decision-Making. The COURAGE to AIM HIGH...	William E. Boden, MD
8:45-9:00 am	Q&A
9:00-10:15 am	Prevention and Public Health Session-Racial and Ethnic Differences	Chair: Robert A. Wild, MD, PhD, MPH, FNLA
9:00-9:20 am	Characterizing Cardiovascular Risk in Hispanics: Lessons Learned from the Multiethnic Study of Atherosclerosis (MESA)	Michael H. Criqui, MD, MPH
9:20-9:40 am	Findings Related to Serum Lipids, The Strong Heart Study	Lyle G. Best, MD
9:40-10:00 am	Dyslipidemia in African Americans: Lessons from the Jackson Heart Study and Beyond	Keith C. Ferdinand, MD, FNLA
10:00-10:15 am	Q&A Panel
10:15-10:45am	Break in Exhibit Hall
10:45 am-12:05 pm	Gender Issues in Coronary Artery Disease	Chair: James M. Falko, MD, FNLA
10:45-11:05 am	Testosterone Therapy and Risk for Coronary Disease	Margaret E. Wierman, MD
11:05-11:25 am	Women, Hormones & Heart Disease Who/what to believe in 2012	Elizabeth Barrett-Connor, MD
11:25-11:45 am	Specific Gender Differences in Quality of Care During and After MI	Vera A. Bittner, MD, MSPH, FNLA
11:45 am-12:05 pm	Q&A Panel
12:05-12:15 pm	NLA News and Business II (PLA)
12:15-1:30pm	Lunch in Exhibit Hall
1:30-2:30 pm	Optimizing Adherence - Overcoming Special Challenges: The Statin USAGE Survey	Chair: Jerome D. Cohen, MD, FNLA
1:30-1:45 pm	Results Overview from Statin Usage Survey	Eliot A. Brinton, MD, FNLA
1:45-2:00 pm	Managing the Statin-Intolerant Patient/Drug-Drug Interactions	Matthew K. Ito, PharmD, CLS, FNLA
2:00-2:15 pm	Improving Physician-Patient Communication/Strategies for Improving Compliance	David T. Nash, MD, MBA, FNLA
2:15-2:30 pm	Q&A Panel/NLA Adherence Committee
2:30-4:00 pm	Debate Session: Is it EPA or EPA & DHA? Only Your Neighborhood Lipidologist Knows For Sure	Chair: Peter P. Toth, MD, PhD, FNLA
2:30-3:00 pm	EPA Only	Harold E. Bays, MD, FNLA
3:00-3:30 pm	EPA and DHA	Terry A. Jacobson, MD, FNLA
3:30-4:00 pm	Q&A Panel
4:00 - 5:30 pm	Special Session on Improving Outcomes in Patients with Severe Familial Hypercholesterolemia	Mary P. McGowan, MD, FNLA
4:00 - 4:05 pm	Introductions	Mary P. McGowan, MD, FNLA
4:05 - 4:20 pm	The Pathophysiology of Severe FH	Mary P. McGowan, MD, FNLA
4:20 - 4:40 pm	Strategies for Early Identification: The Role of Genetic Testing	Daniel J. Rader, MD, FNLA
4:40 - 5:00 pm	Therapeutic Strategies for Optimizing Outcomes in the Severe FH Patient	James A. Underberg,MD, FNLA
5:00 - 5:15 pm	Accelerating Advancements in FH Research and Care: The Patient Perspective	Wenter Blair
5:15 - 5:30 pm	Panel Discussion and Conclusion	Panel Discussion
7:00-9:30 pm	Satellite Dinner Symposium:Reducing CVD Risk in the Patient with High Triglycerides and Metabolic Syndrome or DM-2: You Be the Judge™

Saturday, June 2, 2012

7:00-8:00 am	Breakfast in Exhibit Hall
7:00-8:00 am	Meet the Experts Roundtables - Issues and Case Discussions
7:50-8:00 am	NLA News and Business III (MWLA)
8:00-9:20 am	Atherosclerotic Plaque: Imaging and Dynamics	Chair: Peter P. Toth, MD, PhD, FNLA
8:00-8:20 am	The High-Risk Plaque (HRP) Imaging Study	Valentin Fuster, MD, PhD
8:20-8:40 am	Role for Cholesterol Crystallization in Plaque Rupture	George S. Abela, MD, MSc, MBA, FNLA
8:40-9:00 am	What Are the Appropriate Clinical Indications for Cardiac CT	Matthew J. Budoff, MD
9:00-9:20 am	Q&A Panel
9:20-9:30 am	NLA News and Business IV (NELA)
9:30-10:00 am	Break in Exhibit Hall
10:00-11:35 am	Insulin Resistance, Diabetes & Its Complications	Chair: James M. Falko, MD, FNLA
10:00-10:20 am	Statins and the Risk for New Onset Diabetes	Michael B. Bottorff, PharmD, CLS, FNLA
10:20-10:40 am	Approaching Pre-diabetes	Leigh Perreault, MD
10:40-11:00 am	Impact of Fibrates on Diabetic Retinopathy	Timothy J. Lyons, MD, FNLA
11:00-11:20 am	Metabolic Changes Caused by Weight Loss	Robert H. Eckel, MD, FNLA
11:20-11:35 am	Q&A Panel
11:35 am-12:00 pm	NLA News and Business V (NLA and SWLA) and Poster Winners Announced
12:00-12:30 pm	Special Public Interest Session - "Why We Get Fat in the US?"	Gary Taubes
12:30-1:30 pm	Lunch in Exhibit Hall
1:30-2:30 pm	Oral Presentations
	Hear from the Young Investigator Award winner and top selected abstract winners as they present their research.
2:30-4:30 pm	Special Session: Sugar, Salt and Everything that Peppers the Landscape	Chair: Penny Kris-Etherton, PhD, RD, CLS, FNLA
2:30-2:55 pm	Human Microbiome Metagenomics, Health and Disease	Karen E. Nelson, PhD
	Is High Fructose Syrup a Problem? - Two Perspectives
2:55-3:10 pm	Fructose: The Nutritional Equivelant of "Pandora's Box"	Robert H. Lustig, MD
3:10-3:25 pm	Endocrine and Metabolic Effects of Consuming Beverages Sweetened with Fructose, Glucose, Sucrose and HFCS	Peter J. Havel, DVM, PhD
3:25-3:45 pm	Q&A Session
3:45-4:15 pm	The Need to Reduce Sodium in the US Diet - Challenges and Opportunities	Lawrence Appel, MD, MPH
4:15-4:30 pm	Q&A Session
6:30-7:30 pm	NLA Honors and Awards Ceremony and Reception
7:30-10:30 pm	NLA 10th Anniversary Gala Event - Celebrate a Decade of the National Lipid Association

Sunday, June 3, 2012

7:00-8:00 am	Breakfast
8:00-11:00 am	Concurrent Workshops and Breakout Sessions - Choose one to attend
	Nutrition and Lifestyle Counseling Workshop: New Strategies and Technologies for Clinical Practice	Penny Kris-Etherton, PhD, RD, CLS, FNLA; Geeta Sikand, RD, CDE, CLS; Neal Kaufman, MD, MPH; Julie P. Bolick, MS, RD, CD, CLS
	Lipid and Cardiometabolic Risk Reduction Programs: Strategies for Successful Start-up and Operations.	Ralph La Forge, MSc, CLS, FNLA
	Principles of Evidence-Based Practice: Intensive Workshop	Robert A. Wild, MD, PhD, MPH, FNLA; Kevin C. Maki, PhD, CLS, FNLA; Shari C. Clifton, MLIS; Vera A. Bittner, MD, MSPH, FNLA

*Agenda times are subject to change